Suchergebnisse - "Cornell, Liam"

PubPharm (8)

1

Compositions and methods for predicting response and resistance to CDK4/6 inhibition

enthalten in: Europäisches Patentamt | 2023

von CORNELL LIAM | SHAPIRO GEOFFREY I

2

COMPOSITIONS AND METHODS FOR PREDICTING RESPONSE AND RESISTANCE TO CDK4/6 INHIBITION

enthalten in: Europäisches Patentamt | 2021

von CORNELL LIAM | SHAPIRO GEOFFREY I

3

Compositions and methods for predicting response and resistance to CDK4/6 inhibition

enthalten in: Europäisches Patentamt | 2021

von CORNELL LIAM | SHAPIRO GEOFFREY I

4

MicroRNA-Mediated Suppression of the TGF-β Pathway Confers Transmissible and Reversible CDK4/6 Inhibitor Resistance

enthalten in: Cell reports | 2019

von Cornell, L. | Wander, S. | Visal, T. | +2

5

Palbociclib resistance confers dependence on an FGFR-MAP kinase-mTOR-driven pathway in KRAS-mutant non-small cell lung cancer

enthalten in: Oncotarget | 2018

von Haines, E. | Chen, T. | Kommajosyula, N. | +5

CommentIn: Oncotarget. 2018 Aug 28;9(67):32734-32735. - PMID 30214680

6

DNA-PK-A candidate driver of hepatocarcinogenesis and tissue biomarker that predicts response to treatment and survival

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2015

von Cornell, L. | Munck, J. | Alsinet, C. | +13

7

DNA-PK-A candidate driver of hepatocarcinogenesis and tissue biomarker that predicts response to treatment and survival

enthalten in: Clinical cancer research | 2015

von Cornell, L. | Munck, J. | Alsinet, C. | +13

8

Chemosensitization of cancer cells by KU-0060648, a dual inhibitor of DNA-PK and PI-3K

enthalten in: Molecular cancer therapeutics | 2012

von Munck, J. | Batey, M. | Zhao, Y. | +15

1
[1]